Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001203697 | SCV001374873 | uncertain significance | Aortic valve disease 2 | 2023-11-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln223*) in the SMAD6 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SMAD6 cause disease. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with non-syndromic midline craniosynostosis (PMID: 27606499). ClinVar contains an entry for this variant (Variation ID: 417818). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000477817 | SCV000564288 | risk factor | CRANIOSYNOSTOSIS 7, SUSCEPTIBILITY TO | 2017-04-19 | no assertion criteria provided | literature only |